Safety and Tolerability of BDB-001 Injection in Healthy Subjects
Clinical trial NCT05360927 · COMPLETED
Trial details
- NCT number
- NCT05360927
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-25
- Primary completion
- 2020-12-25
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.